Literature DB >> 32540227

Trauma Service Utilization Increases Cost But Does Not Add Value for Minimally Injured Patients.

Michael Scott1, Waleed Abouelela2, David N Blitzer3, Timothy Murphy4, Gregory Peck5, Matthew Lissauer6.   

Abstract

OBJECTIVE: Trauma care provides value to the critically injured. Our aim was to assess whether trauma team involvement adds value to the care of minimally injured patients and to define its costs.
METHODS: Minimally injured patients admitted to a trauma center were propensity matched and compared by involvement versus no involvement of the trauma service (TS). Demographics, injury severity, complications, length of emergency department stay, mortality, and hospital costs and charges were studied.
RESULTS: A total of 1253 patients were enrolled, with 308 propensity matched to the following groups: TS (n = 102) and no TS (n = 206). TS demonstrated a 30% increase in total charges and costs with no difference in complications. TS did demonstrate decreased time in the emergency department but had an increased delay to operation. Findings were similar when stratified for only lower extremity injuries.
CONCLUSIONS: TS involvement for minimally injured patients does not increase value. Reducing TS involvement while avoiding trauma undertriage may reduce costs to the healthcare system without affecting outcomes.
Copyright © 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cost effectiveness analysis; healthcare costs; trauma care; wounds and injuries

Mesh:

Year:  2020        PMID: 32540227     DOI: 10.1016/j.jval.2020.02.009

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  1 in total

1.  The predictive value of serum lactate to forecast injury severity in trauma-patients increases taking age into account.

Authors:  Paul Hagebusch; Philipp Faul; Christian Ruckes; Philipp Störmann; Ingo Marzi; Reinhard Hoffmann; Uwe Schweigkofler; Yves Gramlich
Journal:  Eur J Trauma Emerg Surg       Date:  2022-07-19       Impact factor: 2.374

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.